Twitter

Scientific Impact at Spanish Home Dialysis National Reunion

Dr. María Quero, Nephrologist at Bellvitge University Hospital, presented “Detection and monitoring of peritonitis in peritoneal dialysis patients using high-resolution ultrasound and artificial intelligence”. Phase 1 trial results for Neosonics® were showcased, alongside our exhibition booth at the 3-day event in Pamplona.

Best oral communication at Congress of the Spanish Society of Ocular Inflammation (SEIOC)

Our abstract, ‘Preliminary Results of a New Automatic Cellularity Detection System Using High-Resolution Ultrasound and Deep Learning in Anterior Uveitis,’ won the Best Communication Award at the 2023 SEIOC. The results correspond to Phase I of the clinical trial for the validation of our device, conducted in collaboration with the Germans Trias i Pujol University […]

Scientific impact at MRF Conference 2023

Poster abstract titled “Non-Invasive Meningitis Screening through High-Frequency Transfontanellar Ultrasound: Insights from the UNITED-Meningitis Study in Mozambique” was among the top 5 and selected for oral presentation. Two other abstracts resulting from our ISGlobal collaboration (cost-effectiveness analysis and proof-of-concept study) were also selected in the poster sessions.

Clinical trials launch

Clinical trials starts in Bellvitge Hospital for new area of care of our medical device. Proof-of-concept phase launched for peritoneal dialysis-related peritonitis in Bellvitge University Hospital (Barcelona, Spain).

Scientific Impact at ESPID

Proof-of-concept study abstract presentation at the 41st Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID). Preliminary results for infant meningitis were extremely well received in this prestigious medical congress.

Clinical trial extension to Morroco

Extension to Rabat (Morroco) for the efficacy phase of the clinical trial for infant meningitis.Quoting the words of our clinical lead Dr. Quique Bassat, this a giant step forward that will undoubtedly contribute to reducing the huge mismatch between the burden of infectious diseases and the few research resources dedicated to them in the country.

Scientific Impact at MRF Conference 2021

2021 MRF Conference poster presentation by Dr. Quique Bassat, clinical lead, epidemiologist and meningitis expert.He shared the study coordinated by the Barcelona Institute of Global Health (ISGlobal) and implemented at Maputo Central Hospital, Mozambique.

Clinical trials launch in Spain and Mozambique

Proof of Concept launch of the clinical trials for infant meningitis, with our non-invasive white blood cell counter for newborns and infants with an open fontanelle. Multisite study with the prestigious Hospital Universitario La Paz (Madrid), Hospital Universitario Quirón Madrid (Pozuelo de Alarcón) and ISGlobal Barcelona at Centro de Investigaçao em Saúde de Manhiça -CISM (Mozambique).